The therapeutic efficacy of ipratropium can be decreased when used in combination with Echothiophate.


The therapeutic efficacy of PHENPROCOUMON can be decreased when used in combination with HYDROXYPROGESTERONE CAPROATE.


The therapeutic efficacy of GESTODENE can be decreased when used in combination with mifepristone.


The therapeutic efficacy of metformin can be decreased when used in combination with Lurasidone.


The therapeutic efficacy of orphenadrine can be decreased when used in combination with malathion.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with BALSALAZIDE.


The therapeutic efficacy of oxybutynin can be decreased when used in combination with Echothiophate.


The therapeutic efficacy of nisoldipine can be decreased when used in combination with Calcium citrate.


The therapeutic efficacy of pentosan polysulfate can be decreased when used in combination with MEGESTROL ACETATE.


The therapeutic efficacy of warfarin can be decreased when used in combination with MEGESTROL ACETATE.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with Pimecrolimus.


The therapeutic efficacy of buspirone can be decreased when used in combination with Yohimbine.


The therapeutic efficacy of Canagliflozin can be decreased when used in combination with DESOGESTREL.


The therapeutic efficacy of Apixaban can be decreased when used in combination with Dienogest.


The therapeutic efficacy of acarbose can be decreased when used in combination with indinavir.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with nimesulide.


The therapeutic efficacy of PAMIDRONIC ACID can be decreased when used in combination with Esomeprazole.


The therapeutic efficacy of Medroxyprogesterone acetate can be decreased when used in combination with Ulipristal.


The therapeutic efficacy of GESTODENE can be decreased when used in combination with Hexobarbital.


The therapeutic efficacy of voglibose can be decreased when used in combination with chlorthalidone.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with celecoxib.


The therapeutic efficacy of Ibandronic Acid can be decreased when used in combination with pantoprazole.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with chlorthalidone.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with mycophenolate mofetil.


The therapeutic efficacy of Travoprost can be decreased when used in combination with Nepafenac.


The therapeutic efficacy of ILOPROST can be decreased when used in combination with ketorolac.


The therapeutic efficacy of folic acid can be decreased when used in combination with leflunomide.


The therapeutic efficacy of glimepiride can be decreased when used in combination with methyclothiazide.


The therapeutic efficacy of gabapentin can be decreased when used in combination with Calcium phosphate.


The therapeutic efficacy of gliclazide can be decreased when used in combination with metolazone.


The therapeutic efficacy of tolbutamide can be decreased when used in combination with metolazone.


The therapeutic efficacy of latanoprost can be decreased when used in combination with tolfenamic acid.


The therapeutic efficacy of PHENYLACETIC ACID can be decreased when used in combination with triamcinolone.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with piperazine.


The therapeutic efficacy of betahistine can be decreased when used in combination with ACRIVASTINE.


The therapeutic efficacy of chlorthalidone can be decreased when used in combination with Masoprocol.


The therapeutic efficacy of Repaglinide can be decreased when used in combination with norethindrone.


The therapeutic efficacy of diazepam can be decreased when used in combination with Yohimbine.


The therapeutic efficacy of gliclazide can be decreased when used in combination with risperidone.


The therapeutic efficacy of Limaprost can be decreased when used in combination with tolmetin.


The therapeutic efficacy of acarbose can be decreased when used in combination with Levomepromazine.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with tolmetin.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with floctafenine.


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Lurasidone.


The therapeutic efficacy of nalbuphine can be decreased when used in combination with naltrexone.


The therapeutic efficacy of epoprostenol can be decreased when used in combination with carprofen.


The therapeutic efficacy of TRIMETHAPHAN can be decreased when used in combination with edrophonium.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with meclofenamic acid.


The therapeutic efficacy of benztropine can be decreased when used in combination with edrophonium.


The therapeutic efficacy of vitamin B12 can be decreased when used in combination with chloramphenicol.


The therapeutic efficacy of oxyphenonium can be decreased when used in combination with Isoflurophate.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with mycophenolic acid.


The therapeutic efficacy of tubocurarine can be decreased when used in combination with NEOSTIGMINE.


The therapeutic efficacy of felbamate can be decreased when used in combination with mianserin.


The therapeutic efficacy of gemeprost can be decreased when used in combination with nimesulide.


The therapeutic efficacy of nateglinide can be decreased when used in combination with DESOGESTREL.


The therapeutic efficacy of Prostaglandin E2 can be decreased when used in combination with NAPROXEN.


The therapeutic efficacy of norgestrel can be decreased when used in combination with ADAPALENE.


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Torasemide.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with Olsalazine.


The therapeutic efficacy of ambenonium can be decreased when used in combination with dipyridamole.


The therapeutic efficacy of CYSTEAMINE can be decreased when used in combination with Trometamol.


The therapeutic efficacy of clopidogrel can be decreased when used in combination with Amrinone.


The therapeutic efficacy of tropicamide can be decreased when used in combination with Demecarium.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with tenoxicam.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with olanzapine.


The therapeutic efficacy of dicyclomine can be decreased when used in combination with Demecarium.


The therapeutic efficacy of Prostaglandin E2 can be decreased when used in combination with etodolac.


The therapeutic efficacy of promazine can be decreased when used in combination with apomorphine.


The therapeutic efficacy of bromazepam can be decreased when used in combination with dyphylline.


The therapeutic efficacy of chenodeoxycholic acid can be decreased when used in combination with ethinyl estradiol.


The therapeutic efficacy of latanoprost can be decreased when used in combination with mycophenolic acid.


The therapeutic efficacy of Prostaglandin E2 can be decreased when used in combination with ETOFENAMATE.


The therapeutic efficacy of misoprostol can be decreased when used in combination with ADAPALENE.


The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Vorinostat.


The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with amobarbital.


The therapeutic efficacy of EDTA can be decreased when used in combination with Nomegestrol.


The therapeutic efficacy of PARAMETHADIONE can be decreased when used in combination with mefloquine.


The therapeutic efficacy of calcitriol can be decreased when used in combination with formestane.


The therapeutic efficacy of chlorthalidone can be decreased when used in combination with suprofen.


The therapeutic efficacy of chlorpropamide can be decreased when used in combination with indapamide.


The therapeutic efficacy of methscopolamine can be decreased when used in combination with donepezil.


The therapeutic efficacy of Remikiren can be decreased when used in combination with acemetacin.


The therapeutic efficacy of Prostaglandin E2 can be decreased when used in combination with oxyphenbutazone.


The therapeutic efficacy of Bethanidine can be decreased when used in combination with acemetacin.


The therapeutic efficacy of D-mannitol can be decreased when used in combination with acemetacin.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with QUINETHAZONE.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with polythiazide.


The therapeutic efficacy of CYSTEAMINE can be decreased when used in combination with omeprazole.


The therapeutic efficacy of BECLOMETHASONE DIPROPIONATE can be decreased when used in combination with mifepristone.


The therapeutic efficacy of Miglustat can be decreased when used in combination with hydrochlorothiazide.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with Etoricoxib.


The therapeutic efficacy of rosiglitazone can be decreased when used in combination with hydrochlorothiazide.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with desipramine.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with chloroquine.


The therapeutic efficacy of dinoprost tromethamine can be decreased when used in combination with nimesulide.


The therapeutic efficacy of NORGESTIMATE can be decreased when used in combination with pentobarbital.


The therapeutic efficacy of dicloxacillin can be decreased when used in combination with minocycline.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with fenoprofen.


The therapeutic efficacy of dinoprost tromethamine can be decreased when used in combination with oxaprozin.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with Pimecrolimus.


The therapeutic efficacy of GLYCEROL PHENYLBUTYRATE can be decreased when used in combination with Fluticasone furoate.


The therapeutic efficacy of estramustine can be decreased when used in combination with Alitretinoin.


The therapeutic efficacy of estramustine can be decreased when used in combination with Mephobarbital.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with salicylamide.


The therapeutic efficacy of indapamide can be decreased when used in combination with Pimecrolimus.


The therapeutic efficacy of clarithromycin can be decreased when used in combination with Vildagliptin.


The therapeutic efficacy of dipivefrin can be decreased when used in combination with betahistine.


The therapeutic efficacy of Methylscopolamine bromide can be decreased when used in combination with galanthamine.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with Iloperidone.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with clozapine.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with ZILEUTON.


The therapeutic efficacy of nateglinide can be decreased when used in combination with Articaine.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with Lumiracoxib.


The therapeutic efficacy of Raltitrexed can be decreased when used in combination with folic acid.


The therapeutic efficacy of dicyclomine can be decreased when used in combination with metoclopramide.


The therapeutic efficacy of digitoxin can be decreased when used in combination with AMILORIDE.


The therapeutic efficacy of tropicamide can be decreased when used in combination with metoclopramide.


The therapeutic efficacy of Dienogest can be decreased when used in combination with phenytoin.


The therapeutic efficacy of hydroxyzine can be decreased when used in combination with Yohimbine.


The therapeutic efficacy of Repaglinide can be decreased when used in combination with TRIPTORELIN.


The therapeutic efficacy of ALENDRONIC ACID can be decreased when used in combination with dexlansoprazole.


The therapeutic efficacy of dicloxacillin can be decreased when used in combination with demeclocycline.


The therapeutic efficacy of ethinyl estradiol can be decreased when used in combination with METHOHEXITAL.


The therapeutic efficacy of dicyclomine can be decreased when used in combination with physostigmine.


The therapeutic efficacy of nimodipine can be decreased when used in combination with CALCIUM CHLORIDE.


The therapeutic efficacy of mesalamine can be decreased when used in combination with Aluminium hydroxide.


The therapeutic efficacy of GLYCEROL PHENYLBUTYRATE can be decreased when used in combination with amcinonide.


The therapeutic efficacy of epoprostenol can be decreased when used in combination with Icatibant.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with leflunomide.


The therapeutic efficacy of codeine can be decreased when used in combination with Dothiepin.


The therapeutic efficacy of Limaprost can be decreased when used in combination with Icatibant.


The therapeutic efficacy of bromocriptine can be decreased when used in combination with Perospirone.


The therapeutic efficacy of misoprostol can be decreased when used in combination with flurbiprofen.


The therapeutic efficacy of 4-PHENYLBUTYRIC ACID can be decreased when used in combination with flurandrenolide.


The therapeutic efficacy of quinidine can be decreased when used in combination with memantine.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with etodolac.


The therapeutic efficacy of pentosan polysulfate can be decreased when used in combination with MEDROGESTONE.


The therapeutic efficacy of warfarin can be decreased when used in combination with MEDROGESTONE.


The therapeutic efficacy of methenamine can be decreased when used in combination with Bismuth subcitrate potassium.


The therapeutic efficacy of Canagliflozin can be decreased when used in combination with triamcinolone.


The therapeutic efficacy of Repaglinide can be decreased when used in combination with furosemide.


The therapeutic efficacy of quinidine can be decreased when used in combination with NEOSTIGMINE.


The therapeutic efficacy of tolazamide can be decreased when used in combination with rapamycin.


The therapeutic efficacy of tolazamide can be decreased when used in combination with mestranol.


The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with physostigmine.


The therapeutic efficacy of clopidogrel can be decreased when used in combination with VERAPAMIL.


The therapeutic efficacy of GLYCEROL PHENYLBUTYRATE can be decreased when used in combination with flumethasone.


The therapeutic efficacy of Trospium can be decreased when used in combination with ambenonium.


The therapeutic efficacy of diethylstilbestrol can be decreased when used in combination with Isotretinoin.


The therapeutic efficacy of dienestrol can be decreased when used in combination with tretinoin.


The therapeutic efficacy of Miglustat can be decreased when used in combination with betamethasone.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with HYDROXYPROGESTERONE CAPROATE.


The therapeutic efficacy of folic acid can be decreased when used in combination with Naftifine.


The therapeutic efficacy of latanoprost can be decreased when used in combination with carprofen.


The therapeutic efficacy of pirenzepine can be decreased when used in combination with physostigmine.


The therapeutic efficacy of Prostaglandin E2 can be decreased when used in combination with acemetacin.


The therapeutic efficacy of Repaglinide can be decreased when used in combination with NORGESTIMATE.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with ZILEUTON.


The therapeutic efficacy of chlorpropamide can be decreased when used in combination with chlorothiazide.


The therapeutic efficacy of Quinagolide can be decreased when used in combination with BREXPIPRAZOLE.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with azelastine.


The therapeutic efficacy of latanoprost can be decreased when used in combination with BENZYDAMINE.


The therapeutic efficacy of tolterodine can be decreased when used in combination with physostigmine.


The therapeutic efficacy of mecamylamine can be decreased when used in combination with edrophonium.


The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with Tipiracil.


The therapeutic efficacy of Corticorelin ovine can be decreased when used in combination with medrysone.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with aspirin.


The therapeutic efficacy of Apixaban can be decreased when used in combination with allylestrenol.


The therapeutic efficacy of benztropine can be decreased when used in combination with donepezil.


The therapeutic efficacy of clarithromycin can be decreased when used in combination with Bivalirudin.


The therapeutic efficacy of glyburide can be decreased when used in combination with mestranol.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with sulfasalazine.


The therapeutic efficacy of Efonidipine can be decreased when used in combination with Glubionate calcium.


The therapeutic efficacy of Lacidipine can be decreased when used in combination with Glubionate calcium.


The therapeutic efficacy of Azelnidipine can be decreased when used in combination with Glubionate calcium.


The therapeutic efficacy of Benidipine can be decreased when used in combination with Glubionate calcium.


The therapeutic efficacy of cilnidipine can be decreased when used in combination with Glubionate calcium.


The therapeutic efficacy of manidipine can be decreased when used in combination with Glubionate calcium.


The therapeutic efficacy of Quinagolide can be decreased when used in combination with chlorprothixene.


The therapeutic efficacy of clonazepam can be decreased when used in combination with aminophylline.


The therapeutic efficacy of dinoprost tromethamine can be decreased when used in combination with resveratrol.


The therapeutic efficacy of pentosan polysulfate can be decreased when used in combination with Dienogest.


The therapeutic efficacy of gliclazide can be decreased when used in combination with Atazanavir.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with mestranol.


The therapeutic efficacy of orphenadrine can be decreased when used in combination with ambenonium.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Telithromycin.


The therapeutic efficacy of anastrozole can be decreased when used in combination with estriol.


The therapeutic efficacy of RIMEXOLONE can be decreased when used in combination with mifepristone.


The therapeutic efficacy of bepridil can be decreased when used in combination with CALCIUM GLUCONATE.


The therapeutic efficacy of 4-PHENYLBUTYRIC ACID can be decreased when used in combination with betamethasone.


The therapeutic efficacy of glipizide can be decreased when used in combination with QUINETHAZONE.


The therapeutic efficacy of gemeprost can be decreased when used in combination with Olsalazine.


The therapeutic efficacy of penbutolol can be decreased when used in combination with acemetacin.


The therapeutic efficacy of nicardipine can be decreased when used in combination with CALCIUM CHLORIDE.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with ETHACRYNIC ACID.


The therapeutic efficacy of clindamycin can be decreased when used in combination with erythromycin.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with hydrochlorothiazide.


The therapeutic efficacy of Aclidinium can be decreased when used in combination with rivastigmine.


The therapeutic efficacy of voglibose can be decreased when used in combination with ETHYNODIOL DIACETATE.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with ETHYNODIOL DIACETATE.


The therapeutic efficacy of metolazone can be decreased when used in combination with Teriflunomide.


The therapeutic efficacy of PHENYLACETIC ACID can be decreased when used in combination with amcinonide.


The therapeutic efficacy of nimesulide can be decreased when used in combination with CALCIUM GLUCONATE.


The therapeutic efficacy of Metixene can be decreased when used in combination with Demecarium.


The therapeutic efficacy of TRIMETHAPHAN can be decreased when used in combination with donepezil.


The therapeutic efficacy of glyburide can be decreased when used in combination with hydroflumethiazide.


The therapeutic efficacy of tolbutamide can be decreased when used in combination with Temsirolimus.


The therapeutic efficacy of gliclazide can be decreased when used in combination with Temsirolimus.


The therapeutic efficacy of ETHACRYNIC ACID can be decreased when used in combination with methotrexate.


The therapeutic efficacy of glipizide can be decreased when used in combination with goserelin.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with reserpine.


The therapeutic efficacy of acarbose can be decreased when used in combination with BENDROFLUMETHIAZIDE.


The therapeutic efficacy of Repaglinide can be decreased when used in combination with QUINETHAZONE.


The therapeutic efficacy of Lercanidipine can be decreased when used in combination with Glubionate calcium.


The therapeutic efficacy of rosiglitazone can be decreased when used in combination with ETONOGESTREL.


The therapeutic efficacy of Miglustat can be decreased when used in combination with ETONOGESTREL.


The therapeutic efficacy of codeine can be decreased when used in combination with clotrimazole.


The therapeutic efficacy of mesoridazine can be decreased when used in combination with apomorphine.


The therapeutic efficacy of Ximelagatran can be decreased when used in combination with HYDROXYPROGESTERONE CAPROATE.


The therapeutic efficacy of mecamylamine can be decreased when used in combination with metoclopramide.


The therapeutic efficacy of indapamide can be decreased when used in combination with tolmetin.


The therapeutic efficacy of Vecuronium can be decreased when used in combination with memantine.


The therapeutic efficacy of pancuronium can be decreased when used in combination with memantine.


The therapeutic efficacy of Prostaglandin E2 can be decreased when used in combination with Magnesium salicylate.


The therapeutic efficacy of Tiludronic Acid can be decreased when used in combination with Esomeprazole.


The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with ambenonium.


The therapeutic efficacy of nifedipine can be decreased when used in combination with Calcium citrate.


The therapeutic efficacy of 3,4-Dihydroxybenzaldehyde can be decreased when used in combination with ETONOGESTREL.


The therapeutic efficacy of Repaglinide can be decreased when used in combination with BREXPIPRAZOLE.


The therapeutic efficacy of misoprostol can be decreased when used in combination with zaltoprofen.


The therapeutic efficacy of Cis-mdp can be decreased when used in combination with lansoprazole.


The therapeutic efficacy of folic acid can be decreased when used in combination with BALSALAZIDE.


The therapeutic efficacy of metformin can be decreased when used in combination with MEGESTROL ACETATE.


The therapeutic efficacy of Tiotropium can be decreased when used in combination with galanthamine.


The therapeutic efficacy of oxyphenonium can be decreased when used in combination with donepezil.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with DESOGESTREL.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with NAPROXEN.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with Droxicam.


The therapeutic efficacy of chlorthalidone can be decreased when used in combination with Olopatadine.


The therapeutic efficacy of tolazamide can be decreased when used in combination with prednisone.


The therapeutic efficacy of nimodipine can be decreased when used in combination with Calcium citrate.


The therapeutic efficacy of apomorphine can be decreased when used in combination with Cariprazine.


The therapeutic efficacy of GLYCEROL PHENYLBUTYRATE can be decreased when used in combination with FLUTICASONE PROPIONATE.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with venlafaxine.


The therapeutic efficacy of betahistine can be decreased when used in combination with ROXATIDINE ACETATE.


The therapeutic efficacy of metolazone can be decreased when used in combination with Salsalate.


The therapeutic efficacy of fludiazepam can be decreased when used in combination with Yohimbine.


The therapeutic efficacy of ATROPINE can be decreased when used in combination with memantine.


The therapeutic efficacy of 4-PHENYLBUTYRIC ACID can be decreased when used in combination with dexamethasone.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with Nilotinib.


The therapeutic efficacy of glipizide can be decreased when used in combination with Iloperidone.


The therapeutic efficacy of dinoprost tromethamine can be decreased when used in combination with SERATRODAST.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with mesalamine.


The therapeutic efficacy of QUINETHAZONE can be decreased when used in combination with tolfenamic acid.


The therapeutic efficacy of polythiazide can be decreased when used in combination with tolfenamic acid.


The therapeutic efficacy of pergolide can be decreased when used in combination with mianserin.


The therapeutic efficacy of clopidogrel can be decreased when used in combination with Clevidipine.


The therapeutic efficacy of Dienogest can be decreased when used in combination with Mephobarbital.


The therapeutic efficacy of Quinagolide can be decreased when used in combination with MOLINDONE.


The therapeutic efficacy of cilnidipine can be decreased when used in combination with Calcium acetate.


The therapeutic efficacy of nimodipine can be decreased when used in combination with Calcium phosphate.


The therapeutic efficacy of chlorpropamide can be decreased when used in combination with Temsirolimus.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with etodolac.


The therapeutic efficacy of Fondaparinux can be decreased when used in combination with Gestrinone.


The therapeutic efficacy of levodopa can be decreased when used in combination with Ziprasidone.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with oxymetazoline.


The therapeutic efficacy of TRIMETHAPHAN can be decreased when used in combination with physostigmine.


The therapeutic efficacy of metolazone can be decreased when used in combination with Naftifine.


The therapeutic efficacy of Halazepam can be decreased when used in combination with Yohimbine.


The therapeutic efficacy of codeine can be decreased when used in combination with imipramine.


The therapeutic efficacy of 3,4-Dihydroxybenzaldehyde can be decreased when used in combination with Levonorgestrel.


The therapeutic efficacy of chlorpropamide can be decreased when used in combination with trichlormethiazide.


The therapeutic efficacy of bromocriptine can be decreased when used in combination with Lurasidone.


The therapeutic efficacy of Travoprost can be decreased when used in combination with ETOFENAMATE.


The therapeutic efficacy of PHENYLACETIC ACID can be decreased when used in combination with paramethasone.


The therapeutic efficacy of argatroban can be decreased when used in combination with progesterone.


The therapeutic efficacy of tolazamide can be decreased when used in combination with Paliperidone.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with betamethasone.


The therapeutic efficacy of chlorpropamide can be decreased when used in combination with epinephrine.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with Propacetamol.


The therapeutic efficacy of rescinnamine can be decreased when used in combination with acemetacin.


The therapeutic efficacy of misoprostol can be decreased when used in combination with meclofenamic acid.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with Propacetamol.


The therapeutic efficacy of propantheline can be decreased when used in combination with metoclopramide.


The therapeutic efficacy of folic acid can be decreased when used in combination with oxaprozin.


The therapeutic efficacy of orphenadrine can be decreased when used in combination with NEOSTIGMINE.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with chlorothiazide.


The therapeutic efficacy of Travoprost can be decreased when used in combination with oxyphenbutazone.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Etoricoxib.


The therapeutic efficacy of voglibose can be decreased when used in combination with chlorothiazide.


The therapeutic efficacy of Propiverine can be decreased when used in combination with memantine.


The therapeutic efficacy of alprostadil can be decreased when used in combination with diclofenac.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with diclofenac.


The therapeutic efficacy of lorazepam can be decreased when used in combination with Pregabalin.


The therapeutic efficacy of folic acid can be decreased when used in combination with suprofen.


The therapeutic efficacy of clarithromycin can be decreased when used in combination with benazepril.


The therapeutic efficacy of benztropine can be decreased when used in combination with physostigmine.


The therapeutic efficacy of enalapril can be decreased when used in combination with acemetacin.


The therapeutic efficacy of misoprostol can be decreased when used in combination with salicylamide.


The therapeutic efficacy of lorazepam can be decreased when used in combination with mefloquine.


The therapeutic efficacy of Delorazepam can be decreased when used in combination with theophylline.


The therapeutic efficacy of pirenzepine can be decreased when used in combination with mefloquine.


The therapeutic efficacy of PHENPROCOUMON can be decreased when used in combination with MEGESTROL ACETATE.


The therapeutic efficacy of metolazone can be decreased when used in combination with PIRFENIDONE.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with MEGESTROL ACETATE.


The therapeutic efficacy of ILOPROST can be decreased when used in combination with ETOFENAMATE.


The therapeutic efficacy of gemeprost can be decreased when used in combination with azelastine.


The therapeutic efficacy of amphotericin b can be decreased when used in combination with haloprogin.


The therapeutic efficacy of glyburide can be decreased when used in combination with Paliperidone.


The therapeutic efficacy of tolazamide can be decreased when used in combination with Asenapine.


The therapeutic efficacy of METYROSINE can be decreased when used in combination with acemetacin.


The therapeutic efficacy of folic acid can be decreased when used in combination with resveratrol.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with histrelin.


The therapeutic efficacy of folic acid can be decreased when used in combination with mycophenolate mofetil.


The therapeutic efficacy of CYSTEAMINE can be decreased when used in combination with rabeprazole.


The therapeutic efficacy of ILOPROST can be decreased when used in combination with oxyphenbutazone.


The therapeutic efficacy of metformin can be decreased when used in combination with hydrocortisone.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with Teriflunomide.


The therapeutic efficacy of clopidogrel can be decreased when used in combination with nilvadipine.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with fenoprofen.


The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with Ulipristal.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with ibuprofen.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with ZILEUTON.


The therapeutic efficacy of codeine can be decreased when used in combination with manidipine.


The therapeutic efficacy of flumethasone can be decreased when used in combination with mifepristone.


The therapeutic efficacy of xylometazoline can be decreased when used in combination with Calcium acetate.


The therapeutic efficacy of QUINETHAZONE can be decreased when used in combination with Magnesium salicylate.


The therapeutic efficacy of polythiazide can be decreased when used in combination with Magnesium salicylate.


The therapeutic efficacy of Pentolinium can be decreased when used in combination with pyridostigmine.


The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Octreotide.


The therapeutic efficacy of misoprostol can be decreased when used in combination with ketorolac.


The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Pasireotide.


The therapeutic efficacy of periciazine can be decreased when used in combination with Rotigotine.


The therapeutic efficacy of dicumarol can be decreased when used in combination with HYDROXYPROGESTERONE CAPROATE.


The therapeutic efficacy of pirenzepine can be decreased when used in combination with galanthamine.


The therapeutic efficacy of Prostaglandin E2 can be decreased when used in combination with flurbiprofen.


The therapeutic efficacy of glyburide can be decreased when used in combination with BENDROFLUMETHIAZIDE.


The therapeutic efficacy of scopolamine can be decreased when used in combination with memantine.


The therapeutic efficacy of Radioiodine can be decreased when used in combination with L-thyroxine.


The therapeutic efficacy of oxyphenonium can be decreased when used in combination with memantine.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with MOXONIDINE.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Masoprocol.


The therapeutic efficacy of codeine can be decreased when used in combination with nevirapine.


The therapeutic efficacy of folic acid can be decreased when used in combination with chloroquine.


The therapeutic efficacy of GLYCEROL PHENYLBUTYRATE can be decreased when used in combination with DESONIDE.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with ketoprofen.


The therapeutic efficacy of Rotigotine can be decreased when used in combination with Blonanserin.


The therapeutic efficacy of DESOGESTREL can be decreased when used in combination with phenobarbital.


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with indapamide.


The therapeutic efficacy of Drospirenone can be decreased when used in combination with Fosphenytoin.


The therapeutic efficacy of tubocurarine can be decreased when used in combination with metoclopramide.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with midodrine.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with Teriflunomide.


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with hydrocortisone.


The therapeutic efficacy of codeine can be decreased when used in combination with clomipramine.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with carprofen.


The therapeutic efficacy of PREDNICARBATE can be decreased when used in combination with mifepristone.


The therapeutic efficacy of acarbose can be decreased when used in combination with Dabrafenib.


The therapeutic efficacy of diethylstilbestrol can be decreased when used in combination with ADAPALENE.


The therapeutic efficacy of clarithromycin can be decreased when used in combination with Darunavir.


The therapeutic efficacy of tolazamide can be decreased when used in combination with Dienogest.


The therapeutic efficacy of dinoprost tromethamine can be decreased when used in combination with azelastine.


The therapeutic efficacy of L-thyroxine can be decreased when used in combination with duloxetine.


The therapeutic efficacy of Latanoprostene BUNOD can be decreased when used in combination with fenbufen.


The therapeutic efficacy of diazepam can be decreased when used in combination with theophylline.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with floctafenine.


The therapeutic efficacy of Pentolinium can be decreased when used in combination with galanthamine.


The therapeutic efficacy of metolazone can be decreased when used in combination with mefenamic acid.


The therapeutic efficacy of indapamide can be decreased when used in combination with tolfenamic acid.


The therapeutic efficacy of estazolam can be decreased when used in combination with dyphylline.


The therapeutic efficacy of trazodone can be decreased when used in combination with Yohimbine.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with LEVOFLOXACIN.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with Aceclofenac.


The therapeutic efficacy of digitoxin can be decreased when used in combination with Eplerenone.


The therapeutic efficacy of Drospirenone can be decreased when used in combination with phenytoin.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with piperazine.


The therapeutic efficacy of clopidogrel can be decreased when used in combination with tolfenamic acid.


The therapeutic efficacy of bepridil can be decreased when used in combination with Calcium acetate.


The therapeutic efficacy of Prostaglandin E2 can be decreased when used in combination with aspirin.


The therapeutic efficacy of Desloratadine can be decreased when used in combination with memantine.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with alclofenac.


The therapeutic efficacy of metformin can be decreased when used in combination with histrelin.


The therapeutic efficacy of Medroxyprogesterone acetate can be decreased when used in combination with thiamylal.


The therapeutic efficacy of epoprostenol can be decreased when used in combination with Apremilast.


The therapeutic efficacy of glimepiride can be decreased when used in combination with ETHACRYNIC ACID.


The therapeutic efficacy of Desloratadine can be decreased when used in combination with NEOSTIGMINE.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with BALSALAZIDE.


The therapeutic efficacy of metolazone can be decreased when used in combination with fenbufen.


The therapeutic efficacy of Quinagolide can be decreased when used in combination with trifluoperazine.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with alclofenac.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with nabumetone.


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with prednisone.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with Icatibant.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with epinephrine.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with linezolid.


The therapeutic efficacy of Pentolinium can be decreased when used in combination with edrophonium.


The therapeutic efficacy of Atracurium besylate can be decreased when used in combination with ambenonium.


The therapeutic efficacy of acarbose can be decreased when used in combination with Lanreotide.


The therapeutic efficacy of xylometazoline can be decreased when used in combination with acemetacin.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with Levonorgestrel.


The therapeutic efficacy of chlorthalidone can be decreased when used in combination with PIRFENIDONE.


The therapeutic efficacy of ropinirole can be decreased when used in combination with Pimavanserin.


The therapeutic efficacy of glipizide can be decreased when used in combination with Levomepromazine.


The therapeutic efficacy of nimesulide can be decreased when used in combination with Glubionate calcium.


The therapeutic efficacy of betahistine can be decreased when used in combination with doxylamine.


The therapeutic efficacy of calcitriol can be decreased when used in combination with fludrocortisone.


The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with HYDROXYPROGESTERONE CAPROATE.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with Drospirenone.


The therapeutic efficacy of acarbose can be decreased when used in combination with NORGESTIMATE.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with Lurasidone.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with nimesulide.


The therapeutic efficacy of voglibose can be decreased when used in combination with piperazine.


The therapeutic efficacy of ETHYNODIOL DIACETATE can be decreased when used in combination with thiopental.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with piperazine.


The therapeutic efficacy of UMECLIDINIUM can be decreased when used in combination with rivastigmine.


The therapeutic efficacy of 4-PHENYLBUTYRIC ACID can be decreased when used in combination with FLUOCORTOLONE.


The therapeutic efficacy of DESOGESTREL can be decreased when used in combination with Tipiracil.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with Choline magnesium trisalicylate.


The therapeutic efficacy of codeine can be decreased when used in combination with Dronedarone.


The therapeutic efficacy of TRIMETHAPHAN can be decreased when used in combination with mefloquine.


The therapeutic efficacy of ANISOTROPINE METHYLBROMIDE can be decreased when used in combination with donepezil.


The therapeutic efficacy of amphotericin b can be decreased when used in combination with oxiconazole.


The therapeutic efficacy of codeine can be decreased when used in combination with ELIGLUSTAT.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with mirtazapine.


The therapeutic efficacy of Canagliflozin can be decreased when used in combination with ethinyl estradiol.


The therapeutic efficacy of propantheline can be decreased when used in combination with NEOSTIGMINE.


The therapeutic efficacy of tolfenamic acid can be decreased when used in combination with Glubionate calcium.


The therapeutic efficacy of GESTODENE can be decreased when used in combination with Ulipristal.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with PIRFENIDONE.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with polymyxin b.


The therapeutic efficacy of betahistine can be decreased when used in combination with prochlorperazine.


The therapeutic efficacy of methscopolamine can be decreased when used in combination with metoclopramide.


The therapeutic efficacy of Latanoprostene BUNOD can be decreased when used in combination with niflumic acid.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with DEXMEDETOMIDINE.


The therapeutic efficacy of chlorpropamide can be decreased when used in combination with DESOGESTREL.


The therapeutic efficacy of Eslicarbazepine acetate can be decreased when used in combination with Pregabalin.


The therapeutic efficacy of mecamylamine can be decreased when used in combination with physostigmine.


The therapeutic efficacy of glyburide can be decreased when used in combination with ETHACRYNIC ACID.


The therapeutic efficacy of loteprednol can be decreased when used in combination with mifepristone.


The therapeutic efficacy of Levalbuterol can be decreased when used in combination with betahistine.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with floctafenine.


The therapeutic efficacy of gliclazide can be decreased when used in combination with Aripiprazole.


The therapeutic efficacy of tolbutamide can be decreased when used in combination with Aripiprazole.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with chloroquine.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with fenoprofen.


The therapeutic efficacy of tolazamide can be decreased when used in combination with Aripiprazole.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with ADAPALENE.


The therapeutic efficacy of FLUOCORTOLONE can be decreased when used in combination with mifepristone.


The therapeutic efficacy of Efonidipine can be decreased when used in combination with acemetacin.


The therapeutic efficacy of rosiglitazone can be decreased when used in combination with DESOGESTREL.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with bacampicillin.


The therapeutic efficacy of Miglustat can be decreased when used in combination with DESOGESTREL.


The therapeutic efficacy of oxyphenonium can be decreased when used in combination with decamethonium.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with niflumic acid.


The therapeutic efficacy of gemeprost can be decreased when used in combination with Propacetamol.


The therapeutic efficacy of glyburide can be decreased when used in combination with prednisone.


The therapeutic efficacy of Linagliptin can be decreased when used in combination with ETHYNODIOL DIACETATE.


The therapeutic efficacy of chlorpropamide can be decreased when used in combination with Estrone sulfate.


The therapeutic efficacy of latanoprost can be decreased when used in combination with Etoricoxib.


The therapeutic efficacy of orphenadrine can be decreased when used in combination with donepezil.


The therapeutic efficacy of chlorpropamide can be decreased when used in combination with Torasemide.


The therapeutic efficacy of glimepiride can be decreased when used in combination with ethinyl estradiol.


The therapeutic efficacy of Latanoprostene BUNOD can be decreased when used in combination with tiaprofenic acid.


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with ETHACRYNIC ACID.


The therapeutic efficacy of Tiotropium can be decreased when used in combination with pyridostigmine.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with diclofenac.


The therapeutic efficacy of misoprostol can be decreased when used in combination with BALSALAZIDE.


The therapeutic efficacy of CYSTEAMINE can be decreased when used in combination with SODIUM BICARBONATE.


The therapeutic efficacy of nimodipine can be decreased when used in combination with acemetacin.


The therapeutic efficacy of Travoprost can be decreased when used in combination with mesalamine.


The therapeutic efficacy of dinoprost tromethamine can be decreased when used in combination with suprofen.


The therapeutic efficacy of Drospirenone can be decreased when used in combination with secobarbital.


The therapeutic efficacy of calcitriol can be decreased when used in combination with estrone.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Magnesium salicylate.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with PIRFENIDONE.


The therapeutic efficacy of Dabigatran etexilate can be decreased when used in combination with ETONOGESTREL.


The therapeutic efficacy of norgestrel can be decreased when used in combination with carbamazepine.


The therapeutic efficacy of tolazamide can be decreased when used in combination with Fosamprenavir.


The therapeutic efficacy of betahistine can be decreased when used in combination with flunarizine.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with ciprofloxacin.


The therapeutic efficacy of Limaprost can be decreased when used in combination with Loxoprofen.


The therapeutic efficacy of polythiazide can be decreased when used in combination with carprofen.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Iloperidone.


The therapeutic efficacy of amphotericin b can be decreased when used in combination with Voriconazole.


The therapeutic efficacy of polythiazide can be decreased when used in combination with NAPROXEN.


The therapeutic efficacy of QUINETHAZONE can be decreased when used in combination with NAPROXEN.


The therapeutic efficacy of VERAPAMIL can be decreased when used in combination with Calcium citrate.


The therapeutic efficacy of alprostadil can be decreased when used in combination with epirizole.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with epirizole.


The therapeutic efficacy of tolazamide can be decreased when used in combination with histrelin.


The therapeutic efficacy of ILOPROST can be decreased when used in combination with salicylamide.


The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with DESOGESTREL.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with BALSALAZIDE.


The therapeutic efficacy of epoprostenol can be decreased when used in combination with Masoprocol.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with pentamidine.


The therapeutic efficacy of chlorpropamide can be decreased when used in combination with HYDROXYPROGESTERONE CAPROATE.


The therapeutic efficacy of Tramadol can be decreased when used in combination with RANOLAZINE.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with Pipotiazine.


The therapeutic efficacy of nilvadipine can be decreased when used in combination with CALCIUM CHLORIDE.


The therapeutic efficacy of folic acid can be decreased when used in combination with nimesulide.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with niflumic acid.


The therapeutic efficacy of Limaprost can be decreased when used in combination with Nepafenac.


The therapeutic efficacy of gemeprost can be decreased when used in combination with resveratrol.


The therapeutic efficacy of Travoprost can be decreased when used in combination with tolmetin.


The therapeutic efficacy of Methylscopolamine bromide can be decreased when used in combination with pyridostigmine.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Octreotide.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with pergolide.


The therapeutic efficacy of CLOCORTOLONE can be decreased when used in combination with mifepristone.


The therapeutic efficacy of voglibose can be decreased when used in combination with Octreotide.


The therapeutic efficacy of Estrone sulfate can be decreased when used in combination with Fosphenytoin.


The therapeutic efficacy of mesalamine can be decreased when used in combination with Esomeprazole.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with zaltoprofen.


The therapeutic efficacy of indapamide can be decreased when used in combination with sulfasalazine.


The therapeutic efficacy of ethotoin can be decreased when used in combination with mianserin.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with BENDROFLUMETHIAZIDE.


The therapeutic efficacy of nateglinide can be decreased when used in combination with diazoxide.


The therapeutic efficacy of voglibose can be decreased when used in combination with BENDROFLUMETHIAZIDE.


The therapeutic efficacy of Trospium can be decreased when used in combination with NEOSTIGMINE.


The therapeutic efficacy of glimepiride can be decreased when used in combination with chlorthalidone.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with ZILEUTON.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with furosemide.


The therapeutic efficacy of Lormetazepam can be decreased when used in combination with aminophylline.


The therapeutic efficacy of GALLAMINE TRIETHIODIDE can be decreased when used in combination with Echothiophate.


The therapeutic efficacy of Limaprost can be decreased when used in combination with suprofen.


The therapeutic efficacy of mecamylamine can be decreased when used in combination with Demecarium.


The therapeutic efficacy of Latanoprostene BUNOD can be decreased when used in combination with aspirin.


The therapeutic efficacy of codeine can be decreased when used in combination with clozapine.


The therapeutic efficacy of glimepiride can be decreased when used in combination with Asenapine.


The therapeutic efficacy of pimozide can be decreased when used in combination with bromocriptine.


The therapeutic efficacy of trichlormethiazide can be decreased when used in combination with fenbufen.


The therapeutic efficacy of 3,4-Dihydroxybenzaldehyde can be decreased when used in combination with MEGESTROL ACETATE.


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Levomepromazine.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with fenbufen.


The therapeutic efficacy of Atracurium besylate can be decreased when used in combination with Echothiophate.


The therapeutic efficacy of benzoic acid can be decreased when used in combination with Halobetasol.


The therapeutic efficacy of Limaprost can be decreased when used in combination with PIRFENIDONE.


The therapeutic efficacy of periciazine can be decreased when used in combination with apomorphine.


The therapeutic efficacy of betahistine can be decreased when used in combination with doxepin.


The therapeutic efficacy of ALFENTANIL can be decreased when used in combination with naltrexone.


The therapeutic efficacy of hyoscyamine can be decreased when used in combination with Demecarium.


The therapeutic efficacy of Tiotropium can be decreased when used in combination with edrophonium.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Flucloxacillin.


The therapeutic efficacy of tiagabine can be decreased when used in combination with mianserin.


The therapeutic efficacy of penicillin g can be decreased when used in combination with doxycycline.


The therapeutic efficacy of dicyclomine can be decreased when used in combination with decamethonium.


The therapeutic efficacy of mesalamine can be decreased when used in combination with ranitidine.


The therapeutic efficacy of tropicamide can be decreased when used in combination with decamethonium.


The therapeutic efficacy of zonisamide can be decreased when used in combination with mianserin.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with Dienogest.


The therapeutic efficacy of acarbose can be decreased when used in combination with nelfinavir.


The therapeutic efficacy of NORGESTIMATE can be decreased when used in combination with Mephobarbital.


The therapeutic efficacy of Empagliflozin can be decreased when used in combination with mestranol.


The therapeutic efficacy of phenindione can be decreased when used in combination with MEDROGESTONE.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Apremilast.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Rifampicin.


The therapeutic efficacy of Vecuronium can be decreased when used in combination with NEOSTIGMINE.


The therapeutic efficacy of tolazamide can be decreased when used in combination with arsenic trioxide.


The therapeutic efficacy of voglibose can be decreased when used in combination with BREXPIPRAZOLE.


The therapeutic efficacy of Pentolinium can be decreased when used in combination with rivastigmine.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with BREXPIPRAZOLE.


The therapeutic efficacy of pancuronium can be decreased when used in combination with NEOSTIGMINE.


The therapeutic efficacy of nitrazepam can be decreased when used in combination with dyphylline.


The therapeutic efficacy of alprostadil can be decreased when used in combination with etodolac.


The therapeutic efficacy of probenecid can be decreased when used in combination with diflunisal.


The therapeutic efficacy of gliclazide can be decreased when used in combination with olanzapine.


The therapeutic efficacy of tolazamide can be decreased when used in combination with progesterone.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with salicylamide.


The therapeutic efficacy of GLYCEROL PHENYLBUTYRATE can be decreased when used in combination with fluocinonide.


The therapeutic efficacy of rosiglitazone can be decreased when used in combination with Pasireotide.


The therapeutic efficacy of gemeprost can be decreased when used in combination with tolmetin.


The therapeutic efficacy of codeine can be decreased when used in combination with terbinafine.


The therapeutic efficacy of Miglustat can be decreased when used in combination with Pasireotide.


The therapeutic efficacy of mecamylamine can be decreased when used in combination with mefloquine.


The therapeutic efficacy of Trospium can be decreased when used in combination with edrophonium.


The therapeutic efficacy of Empagliflozin can be decreased when used in combination with ETONOGESTREL.


The therapeutic efficacy of Norelgestromin can be decreased when used in combination with thiamylal.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with histrelin.


The therapeutic efficacy of ETONOGESTREL can be decreased when used in combination with efavirenz.


The therapeutic efficacy of nateglinide can be decreased when used in combination with ETHACRYNIC ACID.


The therapeutic efficacy of apomorphine can be decreased when used in combination with SERTINDOLE.


The therapeutic efficacy of methazolamide can be decreased when used in combination with acemetacin.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with nabumetone.


The therapeutic efficacy of metolazone can be decreased when used in combination with Lornoxicam.


The therapeutic efficacy of Medroxyprogesterone acetate can be decreased when used in combination with Mephobarbital.


The therapeutic efficacy of metformin can be decreased when used in combination with DESOGESTREL.


The therapeutic efficacy of Travoprost can be decreased when used in combination with mycophenolate mofetil.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Teriflunomide.


The therapeutic efficacy of GLYCEROL PHENYLBUTYRATE can be decreased when used in combination with VALPROIC ACID.


The therapeutic efficacy of adenosine can be decreased when used in combination with dyphylline.


The therapeutic efficacy of chlorthalidone can be decreased when used in combination with Icatibant.


The therapeutic efficacy of fludrocortisone can be decreased when used in combination with mifepristone.


The therapeutic efficacy of Pipamperone can be decreased when used in combination with testosterone propionate.


The therapeutic efficacy of folic acid can be decreased when used in combination with indomethacin.


The therapeutic efficacy of gliclazide can be decreased when used in combination with ETONOGESTREL.


The therapeutic efficacy of Etidronic acid can be decreased when used in combination with lansoprazole.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with methylprednisolone.


The therapeutic efficacy of voglibose can be decreased when used in combination with methylprednisolone.


The therapeutic efficacy of diethylstilbestrol can be decreased when used in combination with secobarbital.


The therapeutic efficacy of clorazepate can be decreased when used in combination with theophylline.


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with QUINETHAZONE.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with ketorolac.


The therapeutic efficacy of NORGESTIMATE can be decreased when used in combination with Tipiracil.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with etodolac.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with ketoprofen.


The therapeutic efficacy of Thioproperazine can be decreased when used in combination with Rotigotine.


The therapeutic efficacy of mecamylamine can be decreased when used in combination with galanthamine.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with Masoprocol.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with sulfamerazine.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with fludrocortisone.


The therapeutic efficacy of misoprostol can be decreased when used in combination with Masoprocol.


The therapeutic efficacy of ETHYNODIOL DIACETATE can be decreased when used in combination with Isotretinoin.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with ritonavir.


The therapeutic efficacy of Limaprost can be decreased when used in combination with BALSALAZIDE.


The therapeutic efficacy of tolbutamide can be decreased when used in combination with arsenic trioxide.


The therapeutic efficacy of voglibose can be decreased when used in combination with ritonavir.


The therapeutic efficacy of Prostaglandin E2 can be decreased when used in combination with fenoprofen.


The therapeutic efficacy of Limaprost can be decreased when used in combination with tiaprofenic acid.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with carprofen.


The therapeutic efficacy of chlorthalidone can be decreased when used in combination with Teriflunomide.


The therapeutic efficacy of gliclazide can be decreased when used in combination with ETHYNODIOL DIACETATE.


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Asenapine.


The therapeutic efficacy of metformin can be decreased when used in combination with dexamethasone.


The therapeutic efficacy of chlorthalidone can be decreased when used in combination with ibuprofen.


The therapeutic efficacy of Latanoprostene BUNOD can be decreased when used in combination with leflunomide.


The therapeutic efficacy of glipizide can be decreased when used in combination with indapamide.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with prednisone.


The therapeutic efficacy of Medroxyprogesterone acetate can be decreased when used in combination with Hexobarbital.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with mycophenolic acid.


The therapeutic efficacy of nimesulide can be decreased when used in combination with Calcium phosphate.


The therapeutic efficacy of alprostadil can be decreased when used in combination with Lumiracoxib.


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with HYDROXYPROGESTERONE CAPROATE.


The therapeutic efficacy of acarbose can be decreased when used in combination with polythiazide.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with nelfinavir.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with Masoprocol.


The therapeutic efficacy of acarbose can be decreased when used in combination with SAQUINAVIR.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with Aceclofenac.


The therapeutic efficacy of alprostadil can be decreased when used in combination with Masoprocol.


The therapeutic efficacy of oxazepam can be decreased when used in combination with theophylline.


The therapeutic efficacy of 4-PHENYLBUTYRIC ACID can be decreased when used in combination with Fluticasone furoate.


The therapeutic efficacy of Medroxyprogesterone acetate can be decreased when used in combination with Fosphenytoin.


The therapeutic efficacy of ILOPROST can be decreased when used in combination with Salsalate.


The therapeutic efficacy of trihexyphenidyl can be decreased when used in combination with metoclopramide.


The therapeutic efficacy of Fesoterodine can be decreased when used in combination with Isoflurophate.


The therapeutic efficacy of alprostadil can be decreased when used in combination with tolfenamic acid.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with tolfenamic acid.


The therapeutic efficacy of Butylscopolamine can be decreased when used in combination with NEOSTIGMINE.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with epirizole.


The therapeutic efficacy of acarbose can be decreased when used in combination with bumetanide.


The therapeutic efficacy of Empagliflozin can be decreased when used in combination with prednisone.


The therapeutic efficacy of hyoscyamine can be decreased when used in combination with metoclopramide.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with celecoxib.


The therapeutic efficacy of gliclazide can be decreased when used in combination with estradiol.


The therapeutic efficacy of calcitriol can be decreased when used in combination with halcinonide.


The therapeutic efficacy of epoprostenol can be decreased when used in combination with tiaprofenic acid.


The therapeutic efficacy of digoxin can be decreased when used in combination with Eplerenone.


The therapeutic efficacy of amphotericin b can be decreased when used in combination with pentamidine.


The therapeutic efficacy of indapamide can be decreased when used in combination with nabumetone.


The therapeutic efficacy of Vecuronium can be decreased when used in combination with physostigmine.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with phenylephrine.


The therapeutic efficacy of Linagliptin can be decreased when used in combination with DESOGESTREL.


The therapeutic efficacy of oxybutynin can be decreased when used in combination with Isoflurophate.


The therapeutic efficacy of benztropine can be decreased when used in combination with ambenonium.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with acemetacin.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with ethionamide.


The therapeutic efficacy of PENTAERYTHRITOL TETRANITRATE can be decreased when used in combination with DESOGESTREL.


The therapeutic efficacy of methicillin can be decreased when used in combination with doxycycline.


The therapeutic efficacy of bacampicillin can be decreased when used in combination with doxycycline.


The therapeutic efficacy of TICARCILLIN can be decreased when used in combination with doxycycline.


The therapeutic efficacy of Tazobactam can be decreased when used in combination with doxycycline.


The therapeutic efficacy of Pivmecillinam can be decreased when used in combination with doxycycline.


The therapeutic efficacy of Pivampicillin can be decreased when used in combination with doxycycline.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with mycophenolate mofetil.


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with diazoxide.


The therapeutic efficacy of Alogliptin can be decreased when used in combination with ETHYNODIOL DIACETATE.


The therapeutic efficacy of glyburide can be decreased when used in combination with nicotinic acid.


The therapeutic efficacy of indapamide can be decreased when used in combination with chloroquine.


The therapeutic efficacy of MOLINDONE can be decreased when used in combination with apomorphine.


The therapeutic efficacy of Liotrix can be decreased when used in combination with mestranol.


The therapeutic efficacy of Salmeterol can be decreased when used in combination with betahistine.


The therapeutic efficacy of Pentolinium can be decreased when used in combination with physostigmine.


The therapeutic efficacy of chlorthalidone can be decreased when used in combination with alclofenac.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with colistin.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with Loxoprofen.


The therapeutic efficacy of VERAPAMIL can be decreased when used in combination with CALCIUM GLUCONATE.


The therapeutic efficacy of metformin can be decreased when used in combination with progesterone.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with ETONOGESTREL.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with ketoprofen.


The therapeutic efficacy of latanoprost can be decreased when used in combination with leflunomide.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with arsenic trioxide.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with methyclothiazide.


The therapeutic efficacy of ATROPINE can be decreased when used in combination with donepezil.


The therapeutic efficacy of dinoprost tromethamine can be decreased when used in combination with ETOFENAMATE.


The therapeutic efficacy of levodopa can be decreased when used in combination with pyridoxine.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with meclofenamic acid.


The therapeutic efficacy of folic acid can be decreased when used in combination with flurbiprofen.


The therapeutic efficacy of Tramadol can be decreased when used in combination with Dronedarone.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with SERATRODAST.


The therapeutic efficacy of voglibose can be decreased when used in combination with Medroxyprogesterone acetate.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Medroxyprogesterone acetate.


The therapeutic efficacy of gabapentin can be decreased when used in combination with CALCIUM CHLORIDE.


The therapeutic efficacy of nisoldipine can be decreased when used in combination with CALCIUM GLUCONATE.


The therapeutic efficacy of 4-PHENYLBUTYRIC ACID can be decreased when used in combination with flumethasone.


The therapeutic efficacy of epoprostenol can be decreased when used in combination with Naftifine.


The therapeutic efficacy of glipizide can be decreased when used in combination with histrelin.


The therapeutic efficacy of MEZLOCILLIN can be decreased when used in combination with chlortetracycline.


The therapeutic efficacy of codeine can be decreased when used in combination with promazine.


The therapeutic efficacy of liothyronine can be decreased when used in combination with diethylstilbestrol.


The therapeutic efficacy of dinoprost tromethamine can be decreased when used in combination with oxyphenbutazone.


The therapeutic efficacy of apomorphine can be decreased when used in combination with MELPERONE.


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Aripiprazole.


The therapeutic efficacy of alprostadil can be decreased when used in combination with meclofenamic acid.


The therapeutic efficacy of Drospirenone can be decreased when used in combination with acemetacin.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with meclofenamic acid.


The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Pregabalin.


The therapeutic efficacy of Apixaban can be decreased when used in combination with HYDROXYPROGESTERONE CAPROATE.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with tenoxicam.


The therapeutic efficacy of VERAPAMIL can be decreased when used in combination with CALCIUM CHLORIDE.


The therapeutic efficacy of glimepiride can be decreased when used in combination with CORTISONE ACETATE.


The therapeutic efficacy of polythiazide can be decreased when used in combination with diclofenac.


The therapeutic efficacy of QUINETHAZONE can be decreased when used in combination with diclofenac.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with Aceclofenac.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with celecoxib.


The therapeutic efficacy of Lercanidipine can be decreased when used in combination with CALCIUM CHLORIDE.


The therapeutic efficacy of procyclidine can be decreased when used in combination with Demecarium.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with oxaprozin.


The therapeutic efficacy of tolbutamide can be decreased when used in combination with hydroflumethiazide.


The therapeutic efficacy of ETHYNODIOL DIACETATE can be decreased when used in combination with carbamazepine.


The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with thiamylal.


The therapeutic efficacy of chlorothiazide can be decreased when used in combination with Loxoprofen.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Pivmecillinam.


The therapeutic efficacy of Tramadol can be decreased when used in combination with Artemether.


The therapeutic efficacy of voglibose can be decreased when used in combination with Asenapine.


The therapeutic efficacy of estramustine can be decreased when used in combination with carbamazepine.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Asenapine.


The therapeutic efficacy of dinoprost tromethamine can be decreased when used in combination with indomethacin.


The therapeutic efficacy of bromocriptine can be decreased when used in combination with Paliperidone.


The therapeutic efficacy of Tramadol can be decreased when used in combination with Midostaurin.


The therapeutic efficacy of Saxagliptin can be decreased when used in combination with rapamycin.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with bromocriptine.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with azelastine.


The therapeutic efficacy of Tramadol can be decreased when used in combination with betaxolol.


The therapeutic efficacy of deslanoside can be decreased when used in combination with spironolactone.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with sertraline.


The therapeutic efficacy of Prostaglandin E2 can be decreased when used in combination with Droxicam.


The therapeutic efficacy of Estrone sulfate can be decreased when used in combination with METHOHEXITAL.


The therapeutic efficacy of piperacillin can be decreased when used in combination with chlortetracycline.


The therapeutic efficacy of codeine can be decreased when used in combination with Delavirdine.


The therapeutic efficacy of benzoic acid can be decreased when used in combination with Mometasone.


The therapeutic efficacy of Linagliptin can be decreased when used in combination with Ziprasidone.


The therapeutic efficacy of TRIMETHAPHAN can be decreased when used in combination with malathion.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with Octreotide.


The therapeutic efficacy of methscopolamine can be decreased when used in combination with ambenonium.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Vorinostat.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with Apremilast.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with SERATRODAST.


The therapeutic efficacy of glyburide can be decreased when used in combination with trichlormethiazide.


The therapeutic efficacy of acarbose can be decreased when used in combination with diazoxide.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with hydrocortisone.


The therapeutic efficacy of eperisone can be decreased when used in combination with CALCIUM CHLORIDE.


The therapeutic efficacy of GALLAMINE TRIETHIODIDE can be decreased when used in combination with pyridostigmine.


The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Lumiracoxib.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with carprofen.


The therapeutic efficacy of chenodeoxycholic acid can be decreased when used in combination with estradiol.


The therapeutic efficacy of galanthamine can be decreased when used in combination with dipyridamole.


The therapeutic efficacy of Isoflurophate can be decreased when used in combination with dipyridamole.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with PSEUDOEPHEDRINE.


The therapeutic efficacy of MIGLITOL can be decreased when used in combination with ceritinib.


The therapeutic efficacy of fludiazepam can be decreased when used in combination with aminophylline.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with tiaprofenic acid.


The therapeutic efficacy of misoprostol can be decreased when used in combination with celecoxib.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with cefuroxime.


The therapeutic efficacy of Bismuth subcitrate potassium can be decreased when used in combination with MAGNESIUM OXIDE.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with ZILEUTON.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with epinephrine.


The therapeutic efficacy of PHENYLACETIC ACID can be decreased when used in combination with flurandrenolide.


The therapeutic efficacy of epoprostenol can be decreased when used in combination with mefenamic acid.


The therapeutic efficacy of folic acid can be decreased when used in combination with tolmetin.


The therapeutic efficacy of acarbose can be decreased when used in combination with methyclothiazide.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Pivampicillin.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with fenbufen.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with ibuprofen.


The therapeutic efficacy of glimepiride can be decreased when used in combination with Drospirenone.


The therapeutic efficacy of benztropine can be decreased when used in combination with malathion.


The therapeutic efficacy of calcitriol can be decreased when used in combination with fluocinonide.


The therapeutic efficacy of Quinagolide can be decreased when used in combination with Levomepromazine.


The therapeutic efficacy of Travoprost can be decreased when used in combination with carprofen.


The therapeutic efficacy of PHENYLACETIC ACID can be decreased when used in combination with CLOBETASOL PROPIONATE.


The therapeutic efficacy of Fluprednidene can be decreased when used in combination with mifepristone.


The therapeutic efficacy of epoprostenol can be decreased when used in combination with Propacetamol.


The therapeutic efficacy of Tiotropium can be decreased when used in combination with physostigmine.


The therapeutic efficacy of gemeprost can be decreased when used in combination with NAPROXEN.


The therapeutic efficacy of Efonidipine can be decreased when used in combination with CALCIUM CHLORIDE.


The therapeutic efficacy of Liotrix can be decreased when used in combination with fluvoxamine.


The therapeutic efficacy of glyburide can be decreased when used in combination with bumetanide.


The therapeutic efficacy of Lubiprostone can be decreased when used in combination with floctafenine.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with bacitracin.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with oxaprozin.


The therapeutic efficacy of PHENYLACETIC ACID can be decreased when used in combination with alclometasone.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with ETHYNODIOL DIACETATE.


The therapeutic efficacy of anastrozole can be decreased when used in combination with QUINESTROL.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Thiosulfuric acid.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with diclofenac.


The therapeutic efficacy of benzoic acid can be decreased when used in combination with fludrocortisone.


The therapeutic efficacy of dihydroergotamine can be decreased when used in combination with mianserin.


The therapeutic efficacy of epoprostenol can be decreased when used in combination with Nepafenac.


The therapeutic efficacy of probenecid can be decreased when used in combination with salicylic acid.


The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Dienogest.


The therapeutic efficacy of Pentolinium can be decreased when used in combination with mefloquine.


The therapeutic efficacy of voglibose can be decreased when used in combination with epinephrine.


The therapeutic efficacy of Fesoterodine can be decreased when used in combination with memantine.


The therapeutic efficacy of nateglinide can be decreased when used in combination with BENDROFLUMETHIAZIDE.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with epinephrine.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with ketorolac.


The therapeutic efficacy of procyclidine can be decreased when used in combination with ambenonium.


The therapeutic efficacy of ethinyl estradiol can be decreased when used in combination with Mephobarbital.


The therapeutic efficacy of betahistine can be decreased when used in combination with cinnarizine.


The therapeutic efficacy of chlorthalidone can be decreased when used in combination with fenbufen.


The therapeutic efficacy of Clodronic Acid can be decreased when used in combination with omeprazole.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with goserelin.


The therapeutic efficacy of Trospium can be decreased when used in combination with physostigmine.


The therapeutic efficacy of gemeprost can be decreased when used in combination with diflunisal.


The therapeutic efficacy of Fosphenytoin can be decreased when used in combination with mefloquine.


The therapeutic efficacy of benazepril can be decreased when used in combination with acemetacin.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with resveratrol.


The therapeutic efficacy of Tiotropium can be decreased when used in combination with Echothiophate.


The therapeutic efficacy of Corticorelin ovine can be decreased when used in combination with flunisolide.


The therapeutic efficacy of DESOGESTREL can be decreased when used in combination with amobarbital.


The therapeutic efficacy of bromazepam can be decreased when used in combination with theophylline.


The therapeutic efficacy of chenodeoxycholic acid can be decreased when used in combination with fenofibrate.


The therapeutic efficacy of dinoprost tromethamine can be decreased when used in combination with ketoprofen.


The therapeutic efficacy of Pranlukast can be decreased when used in combination with amoxapine.


The therapeutic efficacy of GESTODENE can be decreased when used in combination with thiamylal.


The therapeutic efficacy of ethopropazine can be decreased when used in combination with decamethonium.


The therapeutic efficacy of diltiazem can be decreased when used in combination with CALCIUM GLUCONATE.


The therapeutic efficacy of lisinopril can be decreased when used in combination with acemetacin.


The therapeutic efficacy of polythiazide can be decreased when used in combination with mycophenolic acid.


The therapeutic efficacy of QUINETHAZONE can be decreased when used in combination with mycophenolic acid.


The therapeutic efficacy of Iobenguane can be decreased when used in combination with nefazodone.


The therapeutic efficacy of betahistine can be decreased when used in combination with Buclizine.


The therapeutic efficacy of epoprostenol can be decreased when used in combination with oxaprozin.


The therapeutic efficacy of betamethasone can be decreased when used in combination with mifepristone.


The therapeutic efficacy of nateglinide can be decreased when used in combination with rapamycin.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with SERATRODAST.


The therapeutic efficacy of voglibose can be decreased when used in combination with nicotinic acid.


The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with progesterone.


The therapeutic efficacy of ILOPROST can be decreased when used in combination with Lumiracoxib.


The therapeutic efficacy of misoprostol can be decreased when used in combination with Apremilast.


The therapeutic efficacy of acemetacin can be decreased when used in combination with Salbutamol.


The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Vorinostat.


The therapeutic efficacy of Canagliflozin can be decreased when used in combination with piperazine.


The therapeutic efficacy of acemetacin can be decreased when used in combination with metaproterenol.


The therapeutic efficacy of Metixene can be decreased when used in combination with rivastigmine.


The therapeutic efficacy of felodipine can be decreased when used in combination with CALCIUM CHLORIDE.


The therapeutic efficacy of tolbutamide can be decreased when used in combination with QUINETHAZONE.


The therapeutic efficacy of DIPHENOXYLATE can be decreased when used in combination with naltrexone.


The therapeutic efficacy of Latanoprostene BUNOD can be decreased when used in combination with Salsalate.


The therapeutic efficacy of gliclazide can be decreased when used in combination with QUINETHAZONE.


The therapeutic efficacy of misoprostol can be decreased when used in combination with Naftifine.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Rifaximin.


The therapeutic efficacy of acarbose can be decreased when used in combination with norethindrone.


The therapeutic efficacy of Corticorelin ovine can be decreased when used in combination with budesonide.


The therapeutic efficacy of acarbose can be decreased when used in combination with Articaine.


The therapeutic efficacy of biperiden can be decreased when used in combination with pyridostigmine.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with tacrolimus.


The therapeutic efficacy of PERHEXILINE can be decreased when used in combination with Calcium citrate.


The therapeutic efficacy of metolazone can be decreased when used in combination with salicylamide.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with Choline magnesium trisalicylate.


The therapeutic efficacy of trihexyphenidyl can be decreased when used in combination with mefloquine.


The therapeutic efficacy of dicumarol can be decreased when used in combination with Nomegestrol.


The therapeutic efficacy of DIHYDROCODEINE can be decreased when used in combination with naltrexone.


The therapeutic efficacy of Travoprost can be decreased when used in combination with azelastine.


The therapeutic efficacy of benztropine can be decreased when used in combination with Demecarium.


The therapeutic efficacy of hydroflumethiazide can be decreased when used in combination with ZILEUTON.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with pentamidine.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with Lornoxicam.


The therapeutic efficacy of Prostaglandin E2 can be decreased when used in combination with BENZYDAMINE.


The therapeutic efficacy of hydrochlorothiazide can be decreased when used in combination with Icatibant.


The therapeutic efficacy of Propiverine can be decreased when used in combination with edrophonium.


The therapeutic efficacy of Fondaparinux can be decreased when used in combination with Dienogest.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Tazobactam.


The therapeutic efficacy of 4-PHENYLBUTYRIC ACID can be decreased when used in combination with haloperidol.


The therapeutic efficacy of Gliquidone can be decreased when used in combination with Lurasidone.


The therapeutic efficacy of dinoprost tromethamine can be decreased when used in combination with Aceclofenac.


The therapeutic efficacy of Latanoprostene BUNOD can be decreased when used in combination with diflunisal.


The therapeutic efficacy of epinephrine can be decreased when used in combination with mianserin.


The therapeutic efficacy of ATROPINE can be decreased when used in combination with metoclopramide.


The therapeutic efficacy of Sitagliptin can be decreased when used in combination with danazol.


The therapeutic efficacy of BENDROFLUMETHIAZIDE can be decreased when used in combination with tolmetin.


The therapeutic efficacy of tolazamide can be decreased when used in combination with risperidone.


The therapeutic efficacy of Miglustat can be decreased when used in combination with QUINETHAZONE.


The therapeutic efficacy of nateglinide can be decreased when used in combination with methylprednisolone.


The therapeutic efficacy of methscopolamine can be decreased when used in combination with pyridostigmine.


The therapeutic efficacy of dobutamine can be decreased when used in combination with Glubionate calcium.


The therapeutic efficacy of Empagliflozin can be decreased when used in combination with tacrolimus.


The therapeutic efficacy of rosiglitazone can be decreased when used in combination with QUINETHAZONE.


The therapeutic efficacy of glimepiride can be decreased when used in combination with ETONOGESTREL.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Mupirocin.


The therapeutic efficacy of methyclothiazide can be decreased when used in combination with ZILEUTON.


The therapeutic efficacy of liothyronine can be decreased when used in combination with QUINESTROL.


The therapeutic efficacy of Tapentadol can be decreased when used in combination with naltrexone.


The therapeutic efficacy of Unoprostone can be decreased when used in combination with leflunomide.


The therapeutic efficacy of NORGESTIMATE can be decreased when used in combination with Hexobarbital.


The therapeutic efficacy of polythiazide can be decreased when used in combination with epirizole.


The therapeutic efficacy of QUINETHAZONE can be decreased when used in combination with epirizole.


The therapeutic efficacy of dinoprost tromethamine can be decreased when used in combination with Droxicam.


The therapeutic efficacy of tolterodine can be decreased when used in combination with memantine.


The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Articaine.


The therapeutic efficacy of voglibose can be decreased when used in combination with Articaine.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with furosemide.


The therapeutic efficacy of Penicillin G benzathine can be decreased when used in combination with minocycline.


The therapeutic efficacy of PENICILLIN G PROCAINE can be decreased when used in combination with minocycline.


The therapeutic efficacy of Tafluprost can be decreased when used in combination with flurbiprofen.


The therapeutic efficacy of pancuronium can be decreased when used in combination with pyridostigmine.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with ethambutol.


The therapeutic efficacy of misoprostol can be decreased when used in combination with niflumic acid.


The therapeutic efficacy of Latanoprostene BUNOD can be decreased when used in combination with ketoprofen.


The therapeutic efficacy of calcitriol can be decreased when used in combination with desoximetasone.


The therapeutic efficacy of PENTAERYTHRITOL TETRANITRATE can be decreased when used in combination with GESTODENE.


The therapeutic efficacy of Lercanidipine can be decreased when used in combination with Calcium acetate.


The therapeutic efficacy of amisulpride can be decreased when used in combination with bromocriptine.


The therapeutic efficacy of MOXONIDINE can be decreased when used in combination with clomipramine.


The therapeutic efficacy of Prostaglandin E2 can be decreased when used in combination with BALSALAZIDE.


The therapeutic efficacy of alprostadil can be decreased when used in combination with CLONIXIN.


The therapeutic efficacy of quinidine can be decreased when used in combination with edrophonium.


The therapeutic efficacy of tolbutamide can be decreased when used in combination with Iloperidone.


The therapeutic efficacy of gliclazide can be decreased when used in combination with Iloperidone.


The therapeutic efficacy of carboprost trometamol can be decreased when used in combination with Olopatadine.


The therapeutic efficacy of Corticorelin ovine can be decreased when used in combination with formestane.


The therapeutic efficacy of misoprostol can be decreased when used in combination with mycophenolate mofetil.


The therapeutic efficacy of bromocriptine can be decreased when used in combination with mianserin.


The therapeutic efficacy of Levetiracetam can be decreased when used in combination with mianserin.


The therapeutic efficacy of acarbose can be decreased when used in combination with trichlormethiazide.


The therapeutic efficacy of cyclopentolate can be decreased when used in combination with rivastigmine.


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with meropenem.


The therapeutic efficacy of Latanoprostene BUNOD can be decreased when used in combination with Etoricoxib.


The therapeutic efficacy of gliclazide can be decreased when used in combination with CYPROTERONE ACETATE.


The therapeutic efficacy of glimepiride can be decreased when used in combination with piperazine.


The therapeutic efficacy of tolbutamide can be decreased when used in combination with CYPROTERONE ACETATE.


The therapeutic efficacy of chlorthalidone can be decreased when used in combination with flurbiprofen.


The therapeutic efficacy of Milnacipran can be decreased when used in combination with CYPROHEPTADINE.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with olanzapine.


The therapeutic efficacy of anastrozole can be decreased when used in combination with mestranol.


The therapeutic efficacy of Prostaglandin E2 can be decreased when used in combination with indomethacin.


The therapeutic efficacy of Prostaglandin E2 can be decreased when used in combination with azelastine.


The therapeutic efficacy of dinoprost tromethamine can be decreased when used in combination with tolmetin.


The therapeutic efficacy of Latanoprostene BUNOD can be decreased when used in combination with Aceclofenac.


The therapeutic efficacy of CYSTEAMINE can be decreased when used in combination with dexlansoprazole.


The therapeutic efficacy of Tiotropium can be decreased when used in combination with mefloquine.


The therapeutic efficacy of codeine can be decreased when used in combination with Ziprasidone.


The therapeutic efficacy of manidipine can be decreased when used in combination with CALCIUM GLUCONATE.


The therapeutic efficacy of Pioglitazone can be decreased when used in combination with triamcinolone.


The therapeutic efficacy of Azelnidipine can be decreased when used in combination with CALCIUM GLUCONATE.


The therapeutic efficacy of Benidipine can be decreased when used in combination with CALCIUM GLUCONATE.


The therapeutic efficacy of cilnidipine can be decreased when used in combination with CALCIUM GLUCONATE.


The therapeutic efficacy of levodopa can be decreased when used in combination with Asenapine.


The therapeutic efficacy of Efonidipine can be decreased when used in combination with CALCIUM GLUCONATE.


The therapeutic efficacy of Lacidipine can be decreased when used in combination with CALCIUM GLUCONATE.